Sino Medical Sciences Technology Inc. (SHA:688108)

SHA:688108 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	430.32	396.41	291.67	188.64	203.42	287.76
Cash & Short-Term Investments	430.32	396.41	291.67	188.64	203.42	287.76
Cash Growth	27.14%	35.91%	54.62%	-7.27%	-29.31%	-47.18%
Accounts Receivable	24.7	25.14	7.47	8.94	20.28	12
Other Receivables	0.39	0.18	11.42	0.49	0.53	0.86
Receivables	25.09	25.33	18.9	9.43	20.82	12.86
Inventory	86.54	88.79	89.51	118.22	98.13	84.88
Prepaid Expenses	-	0	0	0.01	-	-
Other Current Assets	28.58	9.86	3.31	27.88	32.53	45.3
Total Current Assets	570.53	520.39	403.39	344.18	354.9	430.8
Property, Plant & Equipment	95.86	108.68	135.79	165.95	176.77	172.58
Long-Term Investments	-	-	-	14	18.95	33.65
Goodwill	46.22	46.22	46.22	-	-	-
Other Intangible Assets	188.52	170.53	189.31	53.4	52.87	73.92
Long-Term Deferred Tax Assets	71.09	85.59	111.88	105.33	91.78	44.17
Long-Term Deferred Charges	385.58	417.79	413.88	375.91	369.2	333.07
Other Long-Term Assets	0.04	0.48	0.08	127.05	3.14	14.89
Total Assets	1,358	1,350	1,301	1,186	1,068	1,103

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	27.63	23.2	13.94	20.12	13.41	8.57
Accrued Expenses	57.22	74.04	70.64	57.65	62.19	55.18
Short-Term Debt	105.5	48.44	53.05	53.55	35.54	5.01
Current Portion of Long-Term Debt	4.62	137.05	4.56	0.76	-	-
Current Portion of Leases	6.86	11.4	11.51	14.96	10.95	11.78
Current Income Taxes Payable	-	0.01	0.02	-	-	-
Current Unearned Revenue	0.68	1.59	1.87	1.12	0.79	0.41
Other Current Liabilities	11.61	38.01	36.43	3.12	9.3	11.6
Total Current Liabilities	214.11	333.75	192.02	151.27	132.18	92.56
Long-Term Debt	23.4	-	137	105.3	-	-
Long-Term Leases	10.94	14.83	18.99	24.92	11.83	27.49
Long-Term Unearned Revenue	4.66	5.7	13.32	21	2	1.94
Long-Term Deferred Tax Liabilities	32.63	35.56	40.89	20.22	22.72	21.47
Other Long-Term Liabilities	-	-	-	1.46	11.4	14.47
Total Liabilities	285.74	389.84	402.22	324.17	180.13	157.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	417.95	416.05	413.46	410	410	410
Additional Paid-In Capital	702.09	663.36	651.98	608.92	596.87	527.37
Retained Earnings	-101.83	-152.15	-199.44	-200.94	-161.31	-8.44
Comprehensive Income & Other	-1.01	0.39	0.89	1.97	1.52	-1.09
Total Common Equity	997.23	927.64	866.89	819.96	847.08	927.84
Minority Interest	74.87	32.18	31.45	41.69	40.4	17.33
Shareholders' Equity	1,072	959.83	898.34	861.65	887.48	945.16
Total Liabilities & Equity	1,358	1,350	1,301	1,186	1,068	1,103

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	151.32	211.73	225.11	199.49	58.31	44.27
Net Cash (Debt)	279.01	184.68	66.56	-10.85	145.11	243.48
Net Cash Growth	203.63%	177.44%	-	-	-40.40%	-55.31%
Net Cash Per Share	0.68	0.43	0.18	-0.03	0.36	0.60
Filing Date Shares Outstanding	417.95	416.05	413.46	410	410	410
Total Common Shares Outstanding	417.95	416.05	413.46	410	410	410
Working Capital	356.42	186.64	211.37	192.9	222.72	338.24
Book Value Per Share	2.39	2.23	2.10	2.00	2.07	2.26
Tangible Book Value	762.49	710.9	631.36	766.55	794.21	853.92
Tangible Book Value Per Share	1.82	1.71	1.53	1.87	1.94	2.08
Machinery	267.04	266.28	265.54	286	278.74	226.45
Construction In Progress	3.01	0.29	1.17	1.55	6.66	11.92

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 3, 2026

Data Sources Report a data error